263 The use of 3,4-Diaminopyridine (3,4-DAP) in the management of life-threatening paraneoplastic Lambert Easton Myasthenic Syndrome (LEMS) – A case report.
Saved in:
| Title: | 263 The use of 3,4-Diaminopyridine (3,4-DAP) in the management of life-threatening paraneoplastic Lambert Easton Myasthenic Syndrome (LEMS) – A case report. |
|---|---|
| Authors: | Louis, Kennedy1 (AUTHOR), Tanith, Westerman1 (AUTHOR), Balwinder, Kolotia1 (AUTHOR), Nikolaos, Gorgoraptis1 (AUTHOR), Adam, Januszewski1 (AUTHOR) |
| Source: | Lung Cancer (01695002). 2025 Supplement 1, Vol. 200, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 01695002 |
|---|---|
| DOI: | 10.1016/j.lungcan.2025.108372 |
